Navigation Links
Collegium Pharmaceutical Announces Relocation to Massachusetts
Date:1/17/2013

CANTON, Mass., Jan. 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to Canton, Massachusetts from Cumberland, Rhode Island.

The Company's lead development program is Oxycodone DETERx® (COL-003), a tamper-resistant, extended-release oxycodone product utilizing its proprietary DETERx® technology. The Oxycodone DETERx® formulation was specifically designed to provide and preserve extended release of the active ingredient following the most common methods of product tampering employed by drug abusers (e.g., crushing, chewing, heating for IV injection, etc.). The product is currently in the final stage of clinical development and has been designated Fast Track Status by the FDA due to its potential to address the problem of prescription drug abuse, a major public health issue in the U.S.

Extended-release formulations of opioids (e.g., OxyContin®) are known to be attractive targets for non-medical use since they contain large doses of drug. Crushing these dosage forms can defeat the extended-release properties and result in immediate availability of the opioid, also known as "dose dumping." Crushed formulations are commonly self-administered by abusers orally, intranasally or by IV injection, resulting in a "high." Although marketed formulations carry labels warning against crushing and breaking, there are reports of legitimate pain patients crushing tablets to facilitate swallowing, a practice that significantly increases their risk of serious adverse events.

"We are pleased to have completed our relocation to Massachusetts. The new analytical and development labs will facilitate the completion
'/>"/>

SOURCE Collegium Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Collegium Pharmaceutical to Present at Piper Jaffrays 24th Annual Healthcare Conference
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
9. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Icahn Issues Statement Regarding Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015 The latest clinical ... trials review of H2, 2015 provides an overview ... to enhance decision making capabilities of active stakeholders ... Keratoconus market clinical trials review spread across 72 ... government organizations and supported with 43 tables and ...
(Date:9/1/2015)... OAKS, Calif. , Sept. 1, 2015 /PRNewswire/ ... neuroscience collaboration with Novartis in the areas of ... potential entry into Alzheimer,s disease by teaming up ... Alzheimer,s disease program directed at genetically predisposed individuals ... enables Amgen to focus on the commercialization of ...
(Date:9/1/2015)... PARK, Calif. , Sept. 1, 2015 ... device company that is providing innovative evidence-based solutions for ... company has submitted its preliminary response to the Patent ... petitions for inter partes review (IPR), filed by ... of certain claims in U.S. Patent No. 8,359,102 (the ...
Breaking Medicine Technology:Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 2Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 3Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 4Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2
... Reportlinker.com announces that a new market research ...   Global Ophthalmic Lasers ...   The global outlook series on ... market briefs, and concise summaries of research findings. ...
... (NASDAQ: ARNA ) today announced that ... results after the NASDAQ Global Select Market closes on Wednesday, ... Executive Officer, Jack Lief, will host a conference call at ... the financial results for the fourth quarter and full year ...
Cached Medicine Technology:Global Ophthalmic Lasers Industry 2Global Ophthalmic Lasers Industry 3Global Ophthalmic Lasers Industry 4Global Ophthalmic Lasers Industry 5Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14 3
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, over ... annual convention, the largest single-company convention to date for the state of Utah. , ... to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most exciting ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please join the ... Month , which was established by the Foundation in 2007 with the help ... helping fund more research remains our top priority,” commented Christine Buckley, Executive Director ...
(Date:9/2/2015)... ... September 02, 2015 , ... Mobile working is increasingly more important, as business ... everywhere new mobile apps are being launched, and mobile device usage as a whole ... of their work and personal lives. What's more people are expecting mobile versions of ...
(Date:9/1/2015)... ... ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills wants ... in the United States. , Prostate cancer is to men what breast cancer is ... 7 men. One new case occurs every 2.3 minutes and a man dies from ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... According to ... Association, individuals with type 2 diabetes that participated in a three year study about ... years down the line if they elected weight loss surgery at the onset of ...
Breaking Medicine News(10 mins):Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... Medicine Student Symposium comes at a critical time. The ... for family medicine practitioners by showcasing this dynamic and ... The symposium, launched last year by Universit ... four faculties of medicine and the University of Ottawa. ...
... 2010: Workplace wellness programmes play a vital role in ... Day(1) theme is to encourage employers and employees to ... The European Society of Cardiology(2) is keen to support ... two major initiatives at the next EuroPRevent Meeting(3) in ...
... Washington, DC, September 23, 2010 A new study ... pediatric patients who develop catheter-associated bloodstream infections (CA-BSIs) found ... number of patients who develop these infections. ... Hospitals and Related Institutions Pediatric Intensive Care Unit Focus ...
... a gene that appears to increase a person,s risk ... of the disease. The gene, abbreviated as MTHFD1L, is ... association study. Details are published September 23 in the ... of researchers was led by Margaret A. Pericak-Vance, PhD, ...
... THURSDAY, Sept. 23 (HealthDay News) -- Thursday marks the six-month ... and the day that a number of key provisions of ... signed the Patient Protection and Affordable Care Act on March ... percent of non-elderly Americans by 2019 and, in the interim, ...
... Like a well-crafted football play designed to block the ... body constantly executes complex ,plays, or sequences of events ... Scientists at the University of Rochester Medical Center ... hypertrophy, the unwanted enlargement of the heart and a ...
Cached Medicine News:Health News:McGill to host inter-university Family Medicine Student Symposium 2Health News:ESC announces new initiatives for workplace heart health programs 2Health News:ESC announces new initiatives for workplace heart health programs 3Health News:Study of bloodstream infections reveals inconsistent surveillance methods and reporting 2Health News:Team of researchers finds possible new genetic risk for Alzheimer's disease 2Health News:New Health Reforms Take Effect 2Health News:New Health Reforms Take Effect 3Health News:Molecular 'playbook' for halting heart failure risk factor uncovered 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: